NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Aditya Birla Real Estate Reports Robust Pre-Sales in Q4FY26

Aditya Birla Real Estate (ABREL) has delivered a strong performance in the fourth quarter of fiscal year 2026, with robust pre-sales of INR 428.8 Mn, representing a 11.4% increase compared to the 9MFY26 pre-sales of INR 38,481 Mn. The company's four new launches contributed approximately 85% to the pre-sales, with Birla Arika phase 2 in Gurugram, Birla Trimaya phase 4 in Bengaluru, Birla Taranya in Thane, and Birla Punya phase 2 in Pune being the key contributors.

LaunchLocationSales Progress
Birla Arika phase 2Gurugram97% sold out
Birla Trimaya phase 4Bengaluru85% sold out
Birla TaranyaThane44% sold out
Birla Punya phase 2Pune35% sold out

In addition to the new launches, the company's sustenance sales were also strong in the quarter, with Birla Evam in Bengaluru and Birya Niyaara in Worli jointly contributing approximately 15% to Q4FY26 pre-sales.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Maintaining 'BUY' Recommendation on ABREL

Based on the company's performance, Choice Institutional Equities is maintaining its 'BUY' recommendation on ABREL with a target price of INR 1,880 per share, representing an upside of 21.5%. The target price is unchanged and is based on a SOTP valuation framework.

Investor Takeaway

Investors should consider maintaining a 'BUY' recommendation on ABREL with a target price of INR 1,880/sh.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.